Adenoviral VEGF-B186R127S gene transfer induces angiogenesis and improves perfusion in ischemic heart
Summary: Vascular endothelial growth factor B (VEGF-B) is an interesting therapeutic candidate for coronary artery disease. However, it can also cause ventricular arrhythmias, potentially preventing its use in clinics. We cloned VEGF-B isoforms with different receptor binding profiles to clarify the...
Main Authors: | Henna Korpela, Olli-Pekka Hätinen, Tiina Nieminen, Rahul Mallick, Pyry Toivanen, Jonna Airaksinen, Kaisa Valli, Mikko Hakulinen, Pekka Poutiainen, Jussi Nurro, Seppo Ylä-Herttuala |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221015042 |
Similar Items
-
Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells
by: Rahul Mallick, et al.
Published: (2022-08-01) -
Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia
by: Juho Pajula, et al.
Published: (2022-12-01) -
Isolation of fresh endothelial cells from porcine heart for cardiovascular studies: a new fast protocol suitable for genomic, transcriptomic and cell biology studies
by: Olli-Pekka A. Hätinen, et al.
Published: (2019-08-01) -
Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling
by: Pyry I. Toivanen, et al.
Published: (2017-07-01) -
Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?
by: Rahul Mallick, et al.
Published: (2022-12-01)